Reports + Research
Biocom Appoints Four New Board Members
Leaders from local companies Mintz Levin, NuVasive, Organovo, and Thermo Fisher Scientific were appointed to Biocom’s board of directors. These new members bring their backgrounds in finance, intellectual property, marketing, and research and discovery, to “bolster [Biocom’s] support for [its] member companies throughout the state.”
Call for Best Workplace in San Diego County
For the sixth year in a row, the San Diego Union-Tribune is hosting nominations for top workplaces in the county. The nominations are open online, and the deadline is July 13.
Pfenex Raises $39.4 Million in Public Offering to Advance Osteoporosis Drug
The sale of 7.82 million of common stock netted Pfenex $39.4 million, which the company plans to use to obtain regulatory approval and commercialize and launch their lead drug, PF708. PF708 is a therapeutic equivalent candidate to Forteo for the treatment of arthritis. In the pipeline, the company is also advancing two additional biosimilar candidates to Lucentis and Neulasta.
Editorial: Biotech’s Looming Talent Crisis
Robin Toft from Toft Group Executive Search writes in Xconomy that major demographic shifts and other trends are the first signs of an upcoming talent crisis. She shares five ways that companies can prepare for attracting the next generation of leaders.
Read + Listen
POW! Podcast of the Week
Voice of San Diego has started a podcast called “I Made it in San Diego.” Listen to local leaders describe how they built their business here.
Events
It’s Happening Here
June 11
Suds & Science—From Research to Health Practice will take place 6:30 p.m. to 8 p.m. at the Fleet Science Center.
June 14
BioDuro is holding a symposium on Innovative Approaches to Accelerating Drug Discovery and Development on Thursday, June 14.
June 21
LaunchBio will present the discussion of How AI Will Change Funding Opportunities for Biotech Entrepreneurs.
Client disclosure: Organovo
Tags: Biotech, Biotech Briefing, Blogs, Medical Research, Medicine
